MedPath

Validation of quantitative hepatic fat ultrasonography, by means of a MRI technique.

Recruiting
Conditions
Fatty Liver Disease (FLD)
10018424
10019654
10013317
Registration Number
NL-OMON30811
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Differences with other participants: a study population as heterogenous as possible. However, this does not guarantee large difference in the amount of liver fat.

Exclusion Criteria

viral hepatitis, cirrosis

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Amount of liver fat: pixel intensity (mode, mean, sd) for ultrasonography and<br /><br>peak areas (H2O : fat) for MRI.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Body mass index, waist circumference, blood pressure.</p><br>
© Copyright 2025. All Rights Reserved by MedPath